Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer
- PMID: 9625810
- DOI: 10.3892/ijo.13.1.101
Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer
Abstract
A putative tumor suppressor, PTEN/MMAC1 gene was recently identified at 10q23 and was found to be frequently altered in several types of human tumors. To determine the possible role of this gene in human ovarian tumors, we screened 31 unselected primary epithelial ovarian cancers with matched normal tissues and 7 ovarian cancer cell lines. Two homozygous deletions (4.8%) were detected in primary ovarian tumors by a semi-quantitative multiplex polymerase chain reaction. However, no point mutations were observed in any of the PTEN/MMAC1 coding sequences as determined by denaturing high-performance liquid chromatography and DNA sequencing. These data indicate that PTEN/MMAC1 mutations are rare in ovarian cancers.
Similar articles
-
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.Cancer Res. 1997 Dec 1;57(23):5221-5. Cancer Res. 1997. PMID: 9393738
-
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.Virchows Arch. 2003 May;442(5):437-43. doi: 10.1007/s00428-003-0803-5. Epub 2003 Apr 15. Virchows Arch. 2003. PMID: 12695913
-
PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers.Oncogene. 1998 Jul 30;17(4):475-9. doi: 10.1038/sj.onc.1201956. Oncogene. 1998. PMID: 9696041
-
Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32. doi: 10.1093/jnci/91.22.1922. J Natl Cancer Inst. 1999. PMID: 10564676 Review.
-
Are aberrant transcripts of FHIT, TSG101, and PTEN/MMAC1 oncogenesis related?Int J Mol Med. 1999 May;3(5):491-5. doi: 10.3892/ijmm.3.5.491. Int J Mol Med. 1999. PMID: 10202180 Review.
Cited by
-
Targeted treatment of differentiated and medullary thyroid cancer.J Thyroid Res. 2011;2011:102636. doi: 10.4061/2011/102636. Epub 2011 Aug 2. J Thyroid Res. 2011. PMID: 21826256 Free PMC article.
-
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.BMC Cancer. 2008 Jan 22;8:17. doi: 10.1186/1471-2407-8-17. BMC Cancer. 2008. PMID: 18208621 Free PMC article.
-
Pten, a protean tumor suppressor.Am J Pathol. 2001 Jun;158(6):1895-8. doi: 10.1016/S0002-9440(10)64656-1. Am J Pathol. 2001. PMID: 11395362 Free PMC article. No abstract available.
-
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.Am J Pathol. 2001 Jun;158(6):2097-106. doi: 10.1016/S0002-9440(10)64681-0. Am J Pathol. 2001. PMID: 11395387 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials